Monoclonal Antibodies Cut COVID Deaths

Published on April 4, 2023

Using monoclonal antibodies to fight off COVID-19 is like giving our immune system a superhero sidekick. They swoop in and battle the virus, reducing the risk of getting really sick or dying. A recent study found that when these groundbreaking treatments were given within two days of a positive COVID test, the risk of hospitalization or death was cut by a whopping 39%! That’s like having a trusted ally in the fight against COVID-19. But wait, there’s more! The study also showed that the earlier monoclonal antibodies were administered, the better the results. So, it’s important to act fast and get this superpower boost as soon as possible. This breakthrough research opens up exciting possibilities for improving outcomes for COVID patients and could pave the way for new treatments in the future. If you want to learn more about the incredible science behind monoclonal antibody therapy, dive into the full article!

Monoclonal antibodies have been an effective tool in the battle against COVID-19, reducing the risk of hospitalization or death by 39% for people who started the treatment within two days of a positive test, a new study finds. These treatments were even more effective for…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>